UNIVERSAL HEALTH SVCS ($UHS) posted quarterly earnings results on Monday, October 27th. The company reported earnings of $5.69 per share, beating estimates of $4.84 by $0.85. The company also reported revenue of $4,495,250,000, beating estimates of $4,388,609,872 by $106,640,128.
You can see Quiver Quantitative's $UHS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UNIVERSAL HEALTH SVCS Insider Trading Activity
UNIVERSAL HEALTH SVCS insiders have traded $UHS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $UHS stock by insiders over the last 6 months:
- MARIA RUDERMAN SINGER sold 1,097 shares for an estimated $210,053
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UNIVERSAL HEALTH SVCS Hedge Fund Activity
We have seen 318 institutional investors add shares of UNIVERSAL HEALTH SVCS stock to their portfolio, and 299 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 497,893 shares (-56.1%) from their portfolio in Q2 2025, for an estimated $90,193,316
- BLACKROCK, INC. removed 472,008 shares (-8.6%) from their portfolio in Q2 2025, for an estimated $85,504,249
- SQUAREPOINT OPS LLC removed 379,304 shares (-87.2%) from their portfolio in Q2 2025, for an estimated $68,710,919
- MARSHALL WACE, LLP removed 325,481 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $58,960,883
- PRICE T ROWE ASSOCIATES INC /MD/ added 324,550 shares (+386.3%) to their portfolio in Q2 2025, for an estimated $58,792,232
- FREESTONE GROVE PARTNERS LP added 252,750 shares (+310.5%) to their portfolio in Q2 2025, for an estimated $45,785,662
- BANK OF AMERICA CORP /DE/ removed 229,537 shares (-50.9%) from their portfolio in Q2 2025, for an estimated $41,580,627
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UNIVERSAL HEALTH SVCS Analyst Ratings
Wall Street analysts have issued reports on $UHS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 09/18/2025
- Wells Fargo issued a "Overweight" rating on 08/14/2025
To track analyst ratings and price targets for UNIVERSAL HEALTH SVCS, check out Quiver Quantitative's $UHS forecast page.
UNIVERSAL HEALTH SVCS Price Targets
Multiple analysts have issued price targets for $UHS recently. We have seen 8 analysts offer price targets for $UHS in the last 6 months, with a median target of $212.5.
Here are some recent targets:
- Scott Fidel from Goldman Sachs set a target price of $219.0 on 10/14/2025
- Stephen Baxter from Wells Fargo set a target price of $249.0 on 10/07/2025
- Sarah James from Cantor Fitzgerald set a target price of $227.0 on 10/07/2025
- Andrew Mok from Barclays set a target price of $250.0 on 09/18/2025
- Ben Hendrix from RBC Capital set a target price of $206.0 on 08/19/2025
- Michael Ha from Baird set a target price of $203.0 on 08/14/2025
- Benjamin Rossi from JP Morgan set a target price of $195.0 on 08/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
